FI20145217A - Composition for the binding of aldehydes and free radicals in the digestive tract - Google Patents

Composition for the binding of aldehydes and free radicals in the digestive tract

Info

Publication number
FI20145217A
FI20145217A FI20145217A FI20145217A FI20145217A FI 20145217 A FI20145217 A FI 20145217A FI 20145217 A FI20145217 A FI 20145217A FI 20145217 A FI20145217 A FI 20145217A FI 20145217 A FI20145217 A FI 20145217A
Authority
FI
Finland
Prior art keywords
aldehydes
binding
composition
free radicals
digestive tract
Prior art date
Application number
FI20145217A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Osmo Suovaniemi
Mårten Wikström
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Priority to FI20145217A priority Critical patent/FI20145217A/en
Priority to PCT/FI2015/050143 priority patent/WO2015132472A1/en
Publication of FI20145217A publication Critical patent/FI20145217A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20145217A 2014-03-06 2014-03-06 Composition for the binding of aldehydes and free radicals in the digestive tract FI20145217A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20145217A FI20145217A (en) 2014-03-06 2014-03-06 Composition for the binding of aldehydes and free radicals in the digestive tract
PCT/FI2015/050143 WO2015132472A1 (en) 2014-03-06 2015-03-06 Composition for binding aldehydes and free radicals in the gastrointestinal tract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20145217A FI20145217A (en) 2014-03-06 2014-03-06 Composition for the binding of aldehydes and free radicals in the digestive tract

Publications (1)

Publication Number Publication Date
FI20145217A true FI20145217A (en) 2015-09-07

Family

ID=52686394

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20145217A FI20145217A (en) 2014-03-06 2014-03-06 Composition for the binding of aldehydes and free radicals in the digestive tract

Country Status (2)

Country Link
FI (1) FI20145217A (en)
WO (1) WO2015132472A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496548A (en) 1983-02-04 1985-01-29 Moldowan Mervin J Composition and method for reducing hangover
US4528295A (en) 1983-08-15 1985-07-09 Boris Tabakoff Composition and method for reducing blood acetaldehyde levels
US5202354A (en) 1986-02-18 1993-04-13 Takeda Chemical Industries, Ltd. Composition and method for reducing acetaldehyde toxicity
US5922346A (en) 1997-12-01 1999-07-13 Thione International, Inc. Antioxidant preparation
FI121528B (en) 2000-10-30 2010-12-31 Biohit Oyj Pharmaceutical composition to reduce the risk of sunk in cancer by binding acetaldehyde in saliva, stomach and colon
JP5654726B2 (en) 2004-10-08 2015-01-14 ビオヒット・ユルキネン・オサケユキテュアBiohit Oyj Methods and formulations for binding aldehydes in saliva
US20070098790A1 (en) 2005-10-31 2007-05-03 David Jiang Nutritional supplement for the enhancement of the health of the liver
FI20060501L (en) * 2006-05-22 2007-11-23 Biohit Oyj Composition and method for binding acetaldehyde in the stomach
WO2009137827A2 (en) 2008-05-09 2009-11-12 Tiara Pharmaceuticals, Inc. Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation
FI20115377A (en) * 2011-04-18 2012-10-19 Biohit Oyj Medical products for use in conditions related to microbial infections of upper respiratory and digestive organs

Also Published As

Publication number Publication date
WO2015132472A1 (en) 2015-09-11

Similar Documents

Publication Publication Date Title
DK3220987T3 (en) ELECTRONIC NICOTINE DELIVERY SYSTEM
DE112015002900A5 (en) Filter and filter cartridge
FI20155488A (en) Device for manipulating tubular and round pieces
FI20145195A (en) EUTECTIVE SOLVENT MIXTURES AND USE OF THESE
FI20155228A (en) Device and method for measuring moisture in injection molds
EP3197436A4 (en) Compositions and methods for selective gi tract delivery
FI20155791A (en) Product and procedure
FI20145301A (en) Procedure for checking drain time for centrifugal separator and centrifugal separator
DK3138600T3 (en) The dry powder inhaler
FI20145812A (en) Biomass treatment system and method
FI20145974A (en) Cellulose-based functional composites, energy storage devices and processes for their preparation
FI20145060A (en) Process for the recovery of copper and zinc
FI20165596A (en) Tuote package and process for its preparation
FI20155398A (en) System and procedure for test rooms
SE1451048A1 (en) Procedure and system for controlling disconnectable decelerators
FI20136079A (en) Genetic health assessment procedure and system
FI20155399A (en) Arrangement and procedure for test rooms
GB201411044D0 (en) Copolyestermides and films made therefrom
FI20145410A (en) Method and arrangement for early detection of material properties
FI20145269A (en) Wood dryer and method for drying wood
DK3151893T6 (en) BREATHING ACTIVATED DRY POWDER INHALER
FI20145217A (en) Composition for the binding of aldehydes and free radicals in the digestive tract
FI20145489A (en) PROCEDURE AND DEVICE FOR MANUFACTURING CEMENT
FI20165414L (en) Composition comprising paraffins and process for its production
FI10951U1 (en) Arrangements for the movement of large bags and the like

Legal Events

Date Code Title Description
MM Patent lapsed